<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00946309</url>
  </required_header>
  <id_info>
    <org_study_id>PHS 2333.00</org_study_id>
    <secondary_id>6969</secondary_id>
    <nct_id>NCT00946309</nct_id>
  </id_info>
  <brief_title>Effects of Sulforaphane on Normal Prostate Tissue</brief_title>
  <acronym>PHASE</acronym>
  <official_title>In Vivo Effects of Sulforaphane Supplementation on Normal Human Prostate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fred Hutchinson Cancer Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>VA Puget Sound Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seattle Institute for Biomedical and Clinical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fred Hutchinson Cancer Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators proposed to identify the biological effects of a high-sulforaphane broccoli
      sprout extract in normal prostate tissue.

      The investigators hypothesize that consumption of high-sulforaphane broccoli sprout extract
      every other day will inhibit growth of prostate cancer cells.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gene Expression of Phase II Enzymes</measure>
    <time_frame>Baseline and 5 weeks</time_frame>
    <description>Change in Phase II enzyme expression</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lipid Oxidation</measure>
    <time_frame>Baseline and 5 weeks</time_frame>
    <description>Blood F2 Isoprostane levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DNA Oxidation</measure>
    <time_frame>Five weeks</time_frame>
    <description>Prostate tissue 8-hydroxy-2'-deoxyguanosine (8OHdG) levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DHT Levels</measure>
    <time_frame>Baseline and 5 weeks</time_frame>
    <description>Change in serum dihydrotestosterone (DHT) levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Testosterone Levels</measure>
    <time_frame>Baseline and 5 weeks</time_frame>
    <description>Change in testosterone (T) levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3-alpha-diol Gluconate Levels</measure>
    <time_frame>Baseline and 5 weeks</time_frame>
    <description>Change in serum 3-alpha-diol gluconate(3Î±-DG) levels</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>High Sulforaphane Extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High Sulforaphane Extract (Broccoli Sprout Extract)</intervention_name>
    <description>100 umol sulforaphane, every other day for 5 weeks</description>
    <arm_group_label>High Sulforaphane Extract</arm_group_label>
    <other_name>Broccoli Sprout Extract</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Microcrystalline Cellulose NF (placebo)</intervention_name>
    <description>250 mg every other day for 6 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men aged 40-75 years

          -  Low or intermediate grade prostate cancer (as defined by Gleason sum less than or
             equal to 7) and clinical stage T1 or T2

          -  Serum Prostate specific antigen less than 20 ng/ml

          -  Have elected radical prostatectomy, Brachytherapy or active surveillance as their
             primary treatment

        Exclusion Criteria:

          -  No current physician diagnosed disease (including but not limited to): kidney disease
             requiring dialysis, cognitive deficits, substance abuse

          -  BMI &lt; 18.5 kg/m2 or &gt; 40 kg/m2

          -  Use of any hormonal treatments, including but not limited to testosterone

          -  Any previous cancer diagnosis or treatment within the previous five years, excluding
             non-melanoma skin cancer

          -  Inability or unwillingness to eat a diet that is free of Brassica vegetables for the
             duration of the study

          -  Use of any dietary supplements other than a multivitamin (including herbal
             preparations)

          -  Allergy to cruciferous vegetables or any of the specific fillers used in the placebo

          -  Usual consumption of &gt; 5 servings per week of Brassica vegetables
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel W Lin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fred Hutchinson Cancer Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Puget Sound</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2009</study_first_submitted>
  <study_first_submitted_qc>July 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2009</study_first_posted>
  <results_first_submitted>August 20, 2015</results_first_submitted>
  <results_first_submitted_qc>September 24, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 15, 2016</results_first_posted>
  <last_update_submitted>September 24, 2016</last_update_submitted>
  <last_update_submitted_qc>September 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fred Hutchinson Cancer Research Center</investigator_affiliation>
    <investigator_full_name>Daniel Lin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sulforafan</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment occurred from July 2010 to April 2014 at the VA Puget Sound Health Care System.</recruitment_details>
      <pre_assignment_details>There were no pre-assignment events. Group assignment occurred at the time of participant enrollment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Sulforaphane</title>
          <description>High Sulforaphane Extract (Broccoli Sprout Extract): 100 umol sulforaphane, every other day for 5 weeks</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Microcrystalline Cellulose NF (placebo): 250 mg every other day for 5 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Procedure cancelled/discontinued</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>One participant enrolled to the placebo arm was determined to be ineligible, and was withdrawn from the study Two additional participants enrolled to the placebo arm became ineligible after enrollment, and were withdrawn from the study</population>
      <group_list>
        <group group_id="B1">
          <title>Sulforaphane</title>
          <description>High Sulforaphane Extract (Broccoli Sprout Extract): 100 umol sulforaphane, every other day for 5 weeks</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Microcrystalline Cellulose NF (placebo): 250 mg every other day for 5 weeks</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="23"/>
            <count group_id="B3" value="45"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.6" spread="5.4"/>
                    <measurement group_id="B2" value="62.8" spread="4.3"/>
                    <measurement group_id="B3" value="62.7" spread="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Gene Expression of Phase II Enzymes</title>
        <description>Change in Phase II enzyme expression</description>
        <time_frame>Baseline and 5 weeks</time_frame>
        <population>Due to budget restrictions, outcome data from only collected from the first 20 participants</population>
        <group_list>
          <group group_id="O1">
            <title>Sulforaphane</title>
            <description>High Sulforaphane Extract (Broccoli Sprout Extract): 100 umol sulforaphane, every other day for 5 weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Microcrystalline Cellulose NF (placebo): 250 mg every other day for 5 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Gene Expression of Phase II Enzymes</title>
          <description>Change in Phase II enzyme expression</description>
          <population>Due to budget restrictions, outcome data from only collected from the first 20 participants</population>
          <units>-fold change in expression</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Glutathione peroxidase 4 (GPX4) expression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.36" spread="2.0"/>
                    <measurement group_id="O2" value="0.26" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glutathione S-transferase A2 (GSTa2) expression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="4.1"/>
                    <measurement group_id="O2" value="-0.59" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NAD(P)H:quinone oxidoreductase (NQ01) expression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="1.3"/>
                    <measurement group_id="O2" value="0.42" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RODH5 F2/R2 expression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="2.6"/>
                    <measurement group_id="O2" value="-0.02" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Superoxide dismutase (SOD1) expression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.35" spread="1.1"/>
                    <measurement group_id="O2" value="0.5" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lipid Oxidation</title>
        <description>Blood F2 Isoprostane levels</description>
        <time_frame>Baseline and 5 weeks</time_frame>
        <population>Outcome data were not collected due to budget restrictions</population>
        <group_list>
          <group group_id="O1">
            <title>Sulforaphane</title>
            <description>High Sulforaphane Extract (Broccoli Sprout Extract): 100 umol sulforaphane, every other day for 5 weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Microcrystalline Cellulose NF (placebo): 250 mg every other day for 6 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Lipid Oxidation</title>
          <description>Blood F2 Isoprostane levels</description>
          <population>Outcome data were not collected due to budget restrictions</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>DNA Oxidation</title>
        <description>Prostate tissue 8-hydroxy-2â-deoxyguanosine (8OHdG) levels</description>
        <time_frame>Five weeks</time_frame>
        <population>Outcome data were not collected due to budget restrictions</population>
        <group_list>
          <group group_id="O1">
            <title>Sulforaphane</title>
            <description>High Sulforaphane Extract (Broccoli Sprout Extract): 100 umol sulforaphane, every other day for 5 weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Microcrystalline Cellulose NF (placebo): 250 mg every other day for 6 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>DNA Oxidation</title>
          <description>Prostate tissue 8-hydroxy-2â-deoxyguanosine (8OHdG) levels</description>
          <population>Outcome data were not collected due to budget restrictions</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>DHT Levels</title>
        <description>Change in serum dihydrotestosterone (DHT) levels</description>
        <time_frame>Baseline and 5 weeks</time_frame>
        <population>Due to budget restrictions, outcome data from only collected from the first 25 participants</population>
        <group_list>
          <group group_id="O1">
            <title>Sulforaphane</title>
            <description>High Sulforaphane Extract (Broccoli Sprout Extract): 100 umol sulforaphane, every other day for 5 weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Microcrystalline Cellulose NF (placebo): 250 mg every other day for 6 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>DHT Levels</title>
          <description>Change in serum dihydrotestosterone (DHT) levels</description>
          <population>Due to budget restrictions, outcome data from only collected from the first 25 participants</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.09" spread="77.8"/>
                    <measurement group_id="O2" value="19.33" spread="98.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Testosterone Levels</title>
        <description>Change in testosterone (T) levels</description>
        <time_frame>Baseline and 5 weeks</time_frame>
        <population>Due to budget restrictions, outcome data from only collected from the first 25 participants</population>
        <group_list>
          <group group_id="O1">
            <title>Sulforaphane</title>
            <description>High Sulforaphane Extract (Broccoli Sprout Extract): 100 umol sulforaphane, every other day for 5 weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Microcrystalline Cellulose NF (placebo): 250 mg every other day for 6 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Testosterone Levels</title>
          <description>Change in testosterone (T) levels</description>
          <population>Due to budget restrictions, outcome data from only collected from the first 25 participants</population>
          <units>ng/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-36.79" spread="79.1"/>
                    <measurement group_id="O2" value="5.75" spread="156.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>3-alpha-diol Gluconate Levels</title>
        <description>Change in serum 3-alpha-diol gluconate(3Î±-DG) levels</description>
        <time_frame>Baseline and 5 weeks</time_frame>
        <population>Due to budget restrictions, outcome data from only collected from the first 25 participants</population>
        <group_list>
          <group group_id="O1">
            <title>Sulforaphane</title>
            <description>High Sulforaphane Extract (Broccoli Sprout Extract): 100 umol sulforaphane, every other day for 5 weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Microcrystalline Cellulose NF (placebo): 250 mg every other day for 6 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>3-alpha-diol Gluconate Levels</title>
          <description>Change in serum 3-alpha-diol gluconate(3Î±-DG) levels</description>
          <population>Due to budget restrictions, outcome data from only collected from the first 25 participants</population>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.69" spread="1.6"/>
                    <measurement group_id="O2" value="0.39" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Participants were asked to report the frequency/severity of gastrointestinal-related symptoms weekly.
Adverse event data for the sulforaphane arm is based only on 21 because all data/specimens for one participant (who was ineligible and mistakenly enrolled) was destroyed per Institutional Review Board regulations.</desc>
      <group_list>
        <group group_id="E1">
          <title>Sulforaphane</title>
          <description>High Sulforaphane Extract (Broccoli Sprout Extract): 100 umol sulforaphane, every other day for 5 weeks</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Microcrystalline Cellulose NF (placebo): 250 mg every other day for 5 weeks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Burping (Grade 1)</sub_title>
                <description>Grade 1: Symptomatic but not interfering with activities of daily living daily living</description>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="21"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Burping (Grade 2)</sub_title>
                <description>Grade 2: Symptomatic and interfering with activities of</description>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Abdominal Bloating (Grade 1)</sub_title>
                <description>Grade 1: No change in bowel function or oral intake</description>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="21"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Abdominal bloating (Grade 2)</sub_title>
                <description>Grade 2: Symptomatic decreased oral intake; change in bowel function</description>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Heartburn (Grade 1)</sub_title>
                <counts group_id="E1" events="9" subjects_affected="5" subjects_at_risk="21"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Heartburn (grade 2)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="21"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Vomiting (Grade 1)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Vomiting (Grade 2)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Abdominal Pain (Grade 1)</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="21"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Abdominal Pain (Grade 2)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Flatulence (Grade 1)</sub_title>
                <counts group_id="E1" events="17" subjects_affected="9" subjects_at_risk="21"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Flatulence (Grade 2)</sub_title>
                <counts group_id="E1" events="5" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Diarrhea (Grade 1)</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="21"/>
                <counts group_id="E2" events="11" subjects_affected="7" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Constipation (Grade 1)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E2" events="11" subjects_affected="4" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Constipation (Grade 2)</sub_title>
                <counts group_id="E1" events="7" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Change in Stool Consistency (Grade 1)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="11" subjects_affected="4" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Increase in Appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hyperglycemia (Grade 3)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Light Headed (Grade 1)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache (Grade 1)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Daniel Lin</name_or_title>
      <organization>Fred Hutchinson Cancer Research Center</organization>
      <phone>206-221-0797</phone>
      <email>dwlin@uw.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

